Porosome Therapeutics, Inc.
Home
ABOUT US
PLATFORM
PIPELINE
TEAM
NEWS
Contact
Porosome Therapeutics, Inc.
Home
ABOUT US
PLATFORM
PIPELINE
TEAM
NEWS
Contact
Home
NEWS
Porosome Therapeutic Inc.’s, first therapeutic approach for cystic fibrosis, has just been published as a preprint
Porosome Therapeutic Inc.’s, first therapeutic approach for cystic fibrosis, has just been published as a preprint
Reprogramming the cells secretory machinery: A cystic fibrosis rescue | bioRxiv
Porosome Therapeutics, Inc. Academic Chairman Prof. Bhanu P. Jena recognized with the 2024 “Lipid Science Prize”
Porosome Therapeutics Inc., CSO presented at the recent (April 4-7, 2024) American Physiological Society Meetings in Long Beach, CA, studies on porosome reconstitution therapy that overcomes Cystic Fibrosis (CF) both in human bronchial epithelial cells and in CF mice.
Discovery Underlying Porosome Therapeutics, Inc. Continues to Receive Global Recognition